 |
Thalidomide |
|---|---|
| Trade Name | |
| Orphan Indication | Prevention of graft versus host disease in patients receiving bone marrow transplantation |
| USA Market Approval | USA |
| USA Designation Date | 1988-09-19 00:00:00 |
| Sponsor | Pediatric Pharmaceuticals, Inc.;718 Bradford Avenue;Westfield, NJ, 07090 |
